Back

FINEARTS-HF: Design and Baseline Characteristics

23 May 2023 (10:05 - 10:15)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
IRONMAN: Effect of intravenous iron according to age
Professor I. Squire (Leicester, GB)
Slides Video
Presentation thumbnail
Dapagliflozin and PAD in HF
Doctor J. Butt (Copenhagen, DK)
Slides Video
Presentation thumbnail
Reasons for hospitalisation and mode of death for patients with heart failure and iron deficiency in the IRONMAN randomized trial.
Professor J. Cleland (Glasgow, GB)
Slides Video
Presentation thumbnail
IRONMAN: anaemia, iron deficiency and quality of life in heart failure and its response to IV iron
Professor P. Kalra (Portsmouth, GB)
Slides Video
Presentation thumbnail
IRONMAN: Which marker of iron deficiency best predicts response to intravenous iron in patients with heart failure?
Professor J. Cleland (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials
Video

The Event

Event poster

Heart Failure 2023

23 May 2023 10:05 CET
You may be interested in
thumbnail
Congress Presentation
FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction
thumbnail
Congress Presentation
FINEARTS-HF: new paths to improve outcomes in heart failure
thumbnail
Congress Presentation
Finerenone in patients with severe heart failure: the FINEARTS-HF Trial

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources